NYLI Healthy Hearts ETF
Limited financial coverage for HART.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
This fund employs a passive, indexing-based investment strategy, aiming to replicate the performance of its target index. The benchmark index was developed by IndexIQ LLC, with Candriam Belgium S. A.
- IPO
- 2021
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on HART
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $33.54
- 52W Low
- $26.85
- 50D MA
- $29.94
- 200D MA
- $30.84
- Beta
- 0.76
- RSI (14)
- 62
- Avg Volume
- 566
No earnings-call transcripts are available for HART yet.
- Free Float
- 0.0%
- Shares Outstanding
- 282.41K
- Float Shares
- 0
Held by 19 ETFs
Biggest fund positions in HART by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 22, 16 | McGorry James Joseph | other | 150,000 |
| Mar 22, 16 | KENNEDY JOHN F | other | 25,000 |
| Mar 22, 16 | GREEN DAVID | other | 25,000 |
| Mar 22, 16 | McKee Blaine H. | other | 25,000 |
| Mar 15, 16 | McKee Blaine H. | other | 25,000 |
| Mar 10, 16 | McKee Blaine H. | other | 0 |
| Dec 1, 15 | KENNEDY JOHN F | buy | 9,000 |
| Nov 19, 15 | McGorry James Joseph | buy | 10,000 |
| Nov 17, 15 | GREEN DAVID | buy | 25,000 |
| Aug 24, 15 | KENNEDY JOHN F | buy | 12,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HART coverage
Recent articles, reports, and earnings notes.
No research on HART yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HART report →Rising Pharma Prices Could Give a Beat to HART ETF
etftrends.com · Feb 7
Can Health Care Stocks Outperform Again In 2023?
seekingalpha.com · Jan 11
Healthcare Could Be a Healthy Sector Bet in 2023
etftrends.com · Jan 9
Reliability Carried the Day for Healthcare Sector in 2022
etftrends.com · Jan 3
HART Heavy on Healthcare Bounce Back Plays
etftrends.com · Dec 22
Healthcare Could Be Healthy 2023 Sector Bet
etftrends.com · Dec 14
HART Helpful for Avoiding Healthcare ESG Issues
etftrends.com · Oct 25
FDA Rebound Could Help HART Beat Higher
etftrends.com · Oct 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.